The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Bodes well for next week, closing above 2.2 is key
Remember only 30% free float and even a chunk of that is held pretty tightly
This could easy do 500% on speculation alone, going by what other stocks have done recently.
Not that I'm against these types of moves.
if required to hold for 3 years
the application of an award granted to a Director under the Plan and which is subject to mandatory deferral into shares. Under the terms of the Plan the participant is required to hold the Ordinary Shares within the Plan for a period of three years.
ive got 2.7m shares lol - just need 27p
gla
Novartis, AstraZeneca, the University of Nottingham, the University of Leeds and Cancer Research UK.
Expect SNG type rises
Solid update, can see 1.40 in no time
Agree possibly 0.5 by end of week
BIG rerate coming
I picked up 1.3m through shard also, think I'm averaged under 2p now, so will sit back for 12/24 months and see how this plays out.
My understanding is the analysts at shard are very bullish on DMTR.
Here's hoping to some decent upside going forward
to the public and none of the Placing Shares are being offered or sold in any jurisdiction where it would be unlawful to do so.
Small piece to read on a Sunday evening
https://www.advancedsciencenews.com/are-we-dehumanizing-chemistry/
“Artificial Chemist”
Wont read to much into it, would like to see some 10-20m Volume days to gain some real traction
GLA
2.4 billion revenue, 40k customers DMTR certainly keep good company, I have a feeling its only a matter of time with this one.
15m mcap company working with multiple multi billion pound companies, they must have something good!
The market will soon be waking up to this sleeping giant, hopefully another RNS before the Q&A Monday with 2020 revs to date.